|
|
|
|
Size
|
Re: Haloperidol licence for BPSD
|
Elena Baker-Glenn |
Sat, 27 Jan 2024 15:48:58 +0000 |
814 lines |
Re: Haloperidol licence for BPSD
|
ADIO, Oluwafemi (ROTHERHAM DONCASTER AND SOUTH HUMBER NHS FOUNDATION TRUST) |
Fri, 26 Jan 2024 20:51:02 +0000 |
539 lines |
Re: Haloperidol licence for BPSD
|
Vicky Brown |
Fri, 26 Jan 2024 15:15:36 +0000 |
388 lines |
Re: Haloperidol licence for BPSD
|
Sudip Sikdar |
Fri, 26 Jan 2024 12:36:05 +0000 |
772 lines |
Re: Haloperidol licence for BPSD
|
Sujata Das |
Fri, 26 Jan 2024 12:20:44 +0000 |
544 lines |
Re: Haloperidol licence for BPSD
|
WATKINS, Joanne (HUMBER TEACHING NHS FOUNDATION TRUST) |
Fri, 26 Jan 2024 10:57:31 +0000 |
167 lines |
Re: Haloperidol licence for BPSD
|
Gregor Russell |
Fri, 26 Jan 2024 08:58:41 +0000 |
447 lines |
Haloperidol licence for BPSD
|
ADIO, Oluwafemi (ROTHERHAM DONCASTER AND SOUTH HUMBER NHS FOUNDATION TRUST) |
Fri, 26 Jan 2024 07:24:35 +0000 |
170 lines |
Key survey on blood based biomarkers for dementia
|
RODDA, Joanne (KENT AND MEDWAY NHS AND SOCIAL CARE PARTNERSHIP TRUST) |
Fri, 19 Jan 2024 16:02:21 +0000 |
420 lines |
